← Back to Search

Mapping and Biopsy Study for Kidney Stones

N/A
Recruiting
Led By James Lingeman, MD
Research Sponsored by Indiana Kidney Stone Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Upper urinary tract endoscopic or PERC procedure for kidney stones removal
Be older than 18 years old
Must not have
Bleeding diathesis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will study Randall's plaques in patients with kidney stones to better understand what causes kidney stones.

Who is the study for?
This trial is for people in good health who need surgery to remove kidney stones or treat other urologic conditions at Methodist Urology in Indianapolis, IN. Participants must be able to complete all study requirements and sign a consent form. Those with bleeding disorders, poor health, or unable to follow post-surgery instructions cannot join.
What is being tested?
The study aims to better understand kidney stone causes by examining the papilla (kidney areas where stones attach) during surgery. It involves videotaping renal anatomy and taking papillary biopsies from patients undergoing stone removal procedures.
What are the potential side effects?
Since this trial involves standard surgical procedures for kidney stone removal, side effects may include typical surgical risks such as pain, infection risk at the biopsy site, bleeding, and potential complications related to anesthesia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a procedure to remove kidney stones using endoscopy or PERC.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a bleeding disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: cohortExperimental Treatment1 Intervention
Subjects who are scheduled to undergo a percutaneous kidney stone removal who do not have complicated comorbidities

Find a Location

Who is running the clinical trial?

Indiana University School of MedicineOTHER
192 Previous Clinical Trials
178,807 Total Patients Enrolled
University of ChicagoOTHER
1,056 Previous Clinical Trials
760,309 Total Patients Enrolled
Indiana Kidney Stone InstituteLead Sponsor
15 Previous Clinical Trials
5,585 Total Patients Enrolled

Media Library

cohort Clinical Trial Eligibility Overview. Trial Name: NCT00169806 — N/A
Cystinuria Research Study Groups: cohort
Cystinuria Clinical Trial 2023: cohort Highlights & Side Effects. Trial Name: NCT00169806 — N/A
cohort 2023 Treatment Timeline for Medical Study. Trial Name: NCT00169806 — N/A
~22 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top